Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony E Mega

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Rhode Island Medical Journal (2013)|April 3, 2020
Declining Cancer Rates, Inclining Local Expertise: We Are Pointed in the Right Direction but Work RemainsAnthony E Mega, Fred J Schiffman
Cancer Biology & Therapy|January 16, 2018
Androgen receptor-independent prostate cancer: an emerging clinical entityIlyas Sahin, Anthony E Mega, Benedito A Carneiro
Clinical Nuclear Medicine|May 13, 2024
Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell LymphomaCharles J Milrod, Cory Brown, Anthony E Mega
Rhode Island Medical Journal (2013)|January 27, 2023
Where's My Doctor? The Impact of the Primary Oncologist's Visit with Their Hospitalized PatientsBrianna R Bakow, Fred J Schiffman, Anthony E Mega
Medicine and Health, Rhode Island|February 3, 2011
Why does Rhode Island have the greatest incidence of bladder cancer in the United States?Katherine E Faricy-Anderson, John P Fulton, Anthony E Mega
Journal of Palliative Medicine|August 25, 2009
Are we training our fellows adequately in delivering bad news to patients? A survey of hematology/oncology program directorsHannah D Hebert, James N Butera, Jorge Castillo, et al.
Rhode Island Medical Journal (2013)|April 3, 2020
Prostate Cancer Therapeutics and Their Complications: A Primer for the Primary Care ProviderZachary Brownlee, Andre De Souza, Paul P Koffer, et al.
American Journal of Hematology|February 1, 2005
Lack of bleeding in patients with severe factor VII deficiencyJ Mark Barnett, Kurt C Demel, Anthony E Mega, et al.
Cancer Chemotherapy and Pharmacology|July 16, 2011
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHLJohn L Reagan, Alan Rosmarin, James N Butera, et al.
Urologic Oncology|March 14, 2024
Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical managementYibo Shi, Hanzhang Wang, Borivoj Golijanin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Rhode Island Medical Journal (2013)|April 3, 2020
Declining Cancer Rates, Inclining Local Expertise: We Are Pointed in the Right Direction but Work RemainsAnthony E Mega, Fred J Schiffman
Cancer Biology & Therapy|January 16, 2018
Androgen receptor-independent prostate cancer: an emerging clinical entityIlyas Sahin, Anthony E Mega, Benedito A Carneiro
Clinical Nuclear Medicine|May 13, 2024
Increased PSMA-Targeted 18 F-DCFPyL Uptake in Peripheral T-Cell LymphomaCharles J Milrod, Cory Brown, Anthony E Mega
Rhode Island Medical Journal (2013)|January 27, 2023
Where's My Doctor? The Impact of the Primary Oncologist's Visit with Their Hospitalized PatientsBrianna R Bakow, Fred J Schiffman, Anthony E Mega
Medicine and Health, Rhode Island|February 3, 2011
Why does Rhode Island have the greatest incidence of bladder cancer in the United States?Katherine E Faricy-Anderson, John P Fulton, Anthony E Mega
Journal of Palliative Medicine|August 25, 2009
Are we training our fellows adequately in delivering bad news to patients? A survey of hematology/oncology program directorsHannah D Hebert, James N Butera, Jorge Castillo, et al.
Rhode Island Medical Journal (2013)|April 3, 2020
Prostate Cancer Therapeutics and Their Complications: A Primer for the Primary Care ProviderZachary Brownlee, Andre De Souza, Paul P Koffer, et al.
American Journal of Hematology|February 1, 2005
Lack of bleeding in patients with severe factor VII deficiencyJ Mark Barnett, Kurt C Demel, Anthony E Mega, et al.
Cancer Chemotherapy and Pharmacology|July 16, 2011
Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHLJohn L Reagan, Alan Rosmarin, James N Butera, et al.
Urologic Oncology|March 14, 2024
Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical managementYibo Shi, Hanzhang Wang, Borivoj Golijanin, et al.
Pageof 2